Certified by Founder Lodge
Newpath Partners
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $270,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Newpath is a private venture capital investment fund focused on disruptive treatments and technologies in the life science space. We search for innovative approaches across diverse fields inc
| Company | Date | Round | Raised |
|---|---|---|---|
 Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
 Myeloid Therapeutics |
May, 19 ,2023 | Unknown | $73,000,000 |
 Magnet Biomedicine |
September, 20 ,2023 | Unknown | $50,000,000 |
 Leal Therapeutics |
October, 31 ,2024 | Unknown | $45,000,000 |
 Metsera |
November, 14 ,2024 | Series B | $215,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
TRIANA Biomedicines | $120,000,000 | (Dec 4, 2025)
Ridley | $6,400,000 | (Dec 4, 2025)
Autolane | $7,400,000 | (Dec 4, 2025)
Juniper Biosciences | $40,000,000 | (Dec 4, 2025)
PineAI | $25,000,000 | (Dec 4, 2025)
